{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T03:25:58Z","timestamp":1789961158449,"version":"4.0.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T00:00:00Z","timestamp":1687910400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T00:00:00Z","timestamp":1687910400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1007\/s10067-023-06677-7","type":"journal-article","created":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T07:02:21Z","timestamp":1687935741000},"page":"2855-2860","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Remission rates and risk factors for relapse in pediatric morphea: a multicenter retrospective study of Pediatric Rheumatology Academy (PeRA)-Research Group (RG)"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5637-8553","authenticated-orcid":false,"given":"Esra","family":"Ba\u011flan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7938-2560","authenticated-orcid":false,"given":"Zehra","family":"K\u0131z\u0131lda\u011f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3014-5692","authenticated-orcid":false,"given":"\u015eeng\u00fcl","family":"\u00c7a\u011flayan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1667-2480","authenticated-orcid":false,"given":"Figen","family":"\u00c7akmak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2575-6309","authenticated-orcid":false,"given":"G\u00fcl\u00e7in Otar","family":"Yener","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5602-4595","authenticated-orcid":false,"given":"Semanur","family":"\u00d6zdel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0466-0228","authenticated-orcid":false,"given":"K\u00fcbra","family":"\u00d6zt\u00fcrk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6193-0402","authenticated-orcid":false,"given":"Balahan","family":"Makay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1034-6406","authenticated-orcid":false,"given":"Mustafa","family":"\u00c7akan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3594-7387","authenticated-orcid":false,"given":"Nuray Aktay","family":"Ayaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5079-5644","authenticated-orcid":false,"given":"Bet\u00fcl","family":"S\u00f6zeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8800-0800","authenticated-orcid":false,"given":"\u015eevket Erbil","family":"\u00dcnsal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9007-9653","authenticated-orcid":false,"given":"Mehmet","family":"B\u00fclb\u00fcl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,28]]},"reference":[{"issue":"6","key":"6677_CR1","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1097\/01.bor.0000245727.40630.c3","volume":"18","author":"RM Laxer","year":"2006","unstructured":"Laxer RM, Zulian F (2006) Localized scleroderma. Curr Opin Rheumatol 18(6):606\u2013613","journal-title":"Curr Opin Rheumatol"},{"issue":"1","key":"6677_CR2","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1177\/2397198318798588","volume":"4","author":"T Beukelman","year":"2019","unstructured":"Beukelman T, Xie F, Foeldvari I (2019) The prevalence of localised scleroderma in childhood assessed in the administrative claims data from the United States. J Scleroderma Relat Disord 4(1):77\u201378","journal-title":"J Scleroderma Relat Disord"},{"issue":"3","key":"6677_CR3","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/S0889-857X(02)00010-8","volume":"28","author":"KJ Murray","year":"2002","unstructured":"Murray KJ, Laxer RM (2002) Scleroderma in children and adolescents. Rheum Dis Clin North Am 28(3):603\u2013624","journal-title":"Rheum Dis Clin North Am"},{"issue":"5","key":"6677_CR4","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1093\/rheumatology\/kei251","volume":"45","author":"F Zulian","year":"2006","unstructured":"Zulian F, Athreya B, Laxer R, Nelson A, Feitosa de Oliveira S, Punaro M et al (2006) Juvenile localized scleroderma: clinical and epidemiological features in 750 children. An international study. Rheumatol 45(5):614\u2013620","journal-title":"Rheumatol"},{"issue":"9","key":"6677_CR5","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.1002\/art.21264","volume":"52","author":"F Zulian","year":"2005","unstructured":"Zulian F, Vallongo C, Woo P, Russo R, Ruperto N, Harper J et al (2005) Localized scleroderma in childhood is not just a skin disease. Arthritis Rheum 52(9):2873\u20132881","journal-title":"Arthritis Rheum"},{"issue":"2","key":"6677_CR6","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.jaad.2010.05.045","volume":"64","author":"N Fett","year":"2011","unstructured":"Fett N, Werth VP (2011) Update on morphea: part I. Epidemiology, clinical presentation, and pathogenesis. J Am Acad Dermatol 64(2):217\u2013228","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"6677_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12969-018-0303-4","volume":"17","author":"SC Li","year":"2019","unstructured":"Li SC, Fuhlbrigge RC, Laxer RM, Pope E, Ibarra MF, Stewart K et al (2019) Developing comparative effectiveness studies for a rare, understudied pediatric disease: lessons learned from the CARRA juvenile localized scleroderma consensus treatment plan pilot study. Pediatr Rheumatol Online J 17(1):1\u201312","journal-title":"Pediatr Rheumatol Online J"},{"issue":"6","key":"6677_CR8","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s40272-019-00363-5","volume":"21","author":"I Foeldvari","year":"2019","unstructured":"Foeldvari I (2019) Update on the systemic treatment of pediatric localized scleroderma. Paediatr Drugs 21(6):461\u2013467","journal-title":"Paediatr Drugs"},{"issue":"8","key":"6677_CR9","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1136\/annrheumdis-2018-214697","volume":"78","author":"F Zulian","year":"2019","unstructured":"Zulian F, Culpo R, Sperotto F, Anton J, Avcin T, Baildam EM et al (2019) Consensus-based recommendations for the management of juvenile localised scleroderma. Ann Rheum Dis 78(8):1019\u20131024","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"6677_CR10","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1007\/s00431-018-3144-8","volume":"177","author":"T Constantin","year":"2018","unstructured":"Constantin T, Foeldvari I, Pain CE, P\u00e1link\u00e1s A, H\u00f6ger P, Moll M et al (2018) Development of minimum standards of care for juvenile localized scleroderma. Eur J Pediatr 177(7):961\u2013977","journal-title":"Eur J Pediatr"},{"issue":"1","key":"6677_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12969-018-0295-0","volume":"16","author":"H Lythgoe","year":"2018","unstructured":"Lythgoe H, Almeida B, Bennett J, Bhat C, Bilkhu A, Brennan M et al (2018) Multi-centre national audit of juvenile localised scleroderma: describing current UK practice in disease assessment and management. Pediatr Rheumatol Online J 16(1):1\u20136","journal-title":"Pediatr Rheumatol Online J"},{"issue":"7","key":"6677_CR12","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1002\/art.30264","volume":"63","author":"F Zulian","year":"2011","unstructured":"Zulian F, Martini G, Vallongo C, Vittadello F, Falcini F, Patrizi A et al (2011) Methotrexate treatment in juvenile localized scleroderma: a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 63(7):1998\u20132006","journal-title":"Arthritis Rheum"},{"issue":"12","key":"6677_CR13","doi-asserted-by":"publisher","first-page":"3496","DOI":"10.1002\/art.38853","volume":"66","author":"D Condie","year":"2014","unstructured":"Condie D, Grabell D, Jacobe H (2014) Comparison of outcomes in adults with pediatric-onset morphea and those with adult-onset morphea: a cross-sectional study from the morphea in adults and children cohort. Arthritis Rheumatol 66(12):3496\u20133504","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"6677_CR14","doi-asserted-by":"publisher","first-page":"200","DOI":"10.14744\/nci.2020.25826","volume":"8","author":"B Sozeri","year":"2021","unstructured":"Sozeri B, Emine Sonmez H, Demir F, Cakan M, Ozturk K, Ozdel S et al (2021) Time to collaborate: objectives, design, and methodology of PeRA-Research Group. North Clin Istanb 8(2):200\u2013202. https:\/\/doi.org\/10.14744\/nci.2020.25826","journal-title":"North Clin Istanb"},{"issue":"2","key":"6677_CR15","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.det.2012.12.002","volume":"31","author":"JC Browning","year":"2013","unstructured":"Browning JC (2013) Pediatric morphea. Dermatol Clin 31(2):229\u2013237","journal-title":"Dermatol Clin"},{"issue":"6","key":"6677_CR16","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1016\/j.jaad.2019.01.050","volume":"80","author":"E Kunzler","year":"2019","unstructured":"Kunzler E, Florez-Pollack S, Teske N, O\u2019Brien J, Prasad S, Jacobe H (2019) Linear morphea: clinical characteristics, disease course, and treatment of the Morphea in Adults and Children cohort. J Am Acad Dermatol 80(6):1664\u20131670","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"6677_CR17","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.berh.2018.02.004","volume":"31","author":"F Zulian","year":"2017","unstructured":"Zulian F (2017) Scleroderma in children. Best Pract Res Clin Rheumatol 31(4):576\u2013595","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"10","key":"6677_CR18","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1093\/rheumatology\/ker142","volume":"50","author":"AL Herrick","year":"2011","unstructured":"Herrick AL, Ennis H, Bhushan M, Silman AJ, Baildam EM (2011) Clinical features of childhood localized scleroderma in an incidence cohort. Rheumatol 50(10):1865\u20131868","journal-title":"Rheumatol"},{"issue":"6","key":"6677_CR19","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/j.berh.2007.09.003","volume":"21","author":"RA Gupta","year":"2007","unstructured":"Gupta RA, Fiorentino D (2007) Localized scleroderma and systemic sclerosis: is there a connection? Best Pract Res Clin Rheumatol 21(6):1025\u20131036","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"3","key":"6677_CR20","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1093\/rheumatology\/keaa392","volume":"60","author":"G Martini","year":"2021","unstructured":"Martini G, Saggioro L, Culpo R, Vittadello F, Meneghel A, Zulian F (2021) Mycophenolate mofetil for methotrexate-resistant juvenile localized scleroderma. Rheumatol 60(3):1387\u20131391","journal-title":"Rheumatol"},{"issue":"9","key":"6677_CR21","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1002\/acr.24260","volume":"73","author":"G Fadanelli","year":"2021","unstructured":"Fadanelli G, Agazzi A, Vittadello F, Meneghel A, Zulian F, Martini G (2021) Methotrexate in linear scleroderma: long-term efficacy in fifty children from a single pediatric rheumatology center. Arthritis Care Res 73(9):1259\u20131263","journal-title":"Arthritis Care Res"},{"issue":"7","key":"6677_CR22","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.autrev.2018.02.004","volume":"17","author":"G Martini","year":"2018","unstructured":"Martini G, Fadanelli G, Agazzi A, Vittadello F, Meneghel A, Zulian F (2018) Disease course and long-term outcome of juvenile localized scleroderma: experience from a single pediatric rheumatology centre and literature review. Autoimmun Rev 17(7):727\u2013734","journal-title":"Autoimmun Rev"},{"issue":"1","key":"6677_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1546-0096-11-5","volume":"11","author":"NM Wulffraat","year":"2013","unstructured":"Wulffraat NM, Vastert B (2013) Time to share. Pediatr Rheumatol Online J 11(1):1\u20135","journal-title":"Pediatr Rheumatol Online J"},{"issue":"10","key":"6677_CR24","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1093\/rheumatology\/keu212","volume":"53","author":"DP Hawley","year":"2014","unstructured":"Hawley DP, Pain CE, Baildam EM, Murphy R, Taylor AE, Foster HE (2014) United Kingdom survey of current management of juvenile localized scleroderma. Rheumatol 53(10):1849\u20131854","journal-title":"Rheumatol"},{"issue":"5","key":"6677_CR25","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.jaad.2012.01.011","volume":"67","author":"W Johnson","year":"2012","unstructured":"Johnson W, Jacobe H (2012) Morphea in adults and children cohort II: patients with morphea experience delay in diagnosis and large variation in treatment. J Am Acad Dermatol 67(5):881\u2013889","journal-title":"J Am Acad Dermatol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-023-06677-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-023-06677-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-023-06677-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T14:08:30Z","timestamp":1699884510000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-023-06677-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,28]]},"references-count":25,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["6677"],"URL":"https:\/\/doi.org\/10.1007\/s10067-023-06677-7","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,28]]},"assertion":[{"value":"18 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the responsible ethics review board (ethics approval number: 2022-05\/07).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}